Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 8,205 | 6,595 | 4,747 | 4,828 | 5,158 |
| Operating Income | -8,205 | -6,595 | -4,747 | -4,828 | -5,158 |
| Other Income | 194 | -77 | -39 | -4 | -39 |
| Pre-tax Income | -8,011 | -6,672 | -4,786 | -4,832 | -5,197 |
| Net Income Continuous | -8,011 | -6,672 | -4,786 | -4,832 | -5,197 |
| Net Income | $-8,011 | $-6,672 | $-4,786 | $-4,832 | $-5,197 |
| EPS Basic Total Ops | -0.90 | -0.75 | -0.60 | -0.60 | -0.60 |
| EPS Basic Continuous Ops | -0.95 | -0.79 | -0.57 | -0.58 | -0.62 |
| EPS Diluted Total Ops | -0.90 | -0.75 | -0.60 | -0.60 | -0.60 |
| EPS Diluted Continuous Ops | -0.95 | -0.79 | -0.57 | -0.58 | -0.62 |
| EBITDA(a) | $-8,203 | $-6,593 | $-4,745 | $-4,826 | $-5,152 |